Several studies show that hypothalamic inflammation participates in the development and pathogenesis of metabolic diseases, such as obesity, diabetes, metabolic syndrome, hypertension, and dyslipidemia, mainly by affecting the homeostasis of food intake, energy balance, insulin and leptin signaling, and glucose metabolism in liver and fatty acid oxidation [59,60]. The gene discussed is LEP; the disease is obesity disorder.